← Analyst Upside
AU · rank #10 · 2026-06-05
PAYS
NASDAQ · $390M
verdict · PROCEED
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 0.438 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$0.05 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 1 |
| Insider signal (90d) $0 across 0 unique buyers. | -0.186 |
| Analyst upside Consensus target $9.95 | +42.8% |
| Momentum acceleration 3-month minus 12-month momentum. | +71.43% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | 4.60 |
| Gross margin TTM | +60.4% |
| 52w high | $8.88 |
| Market cap | $390M |
The AI research card
Independent qualitative review of each pick before the order is placed.
Summary
Paysign Inc. is a fintech company that provides prepaid card programs and processing services, specializing in pharmaceutical co-pay assistance, corporate rewards, and plasma donation programs.
Rationale
The high analyst upside percentage, strong analyst rating, and positive EPS revisions suggest a potential for significant price appreciation driven by favorable analyst sentiment and improving earnings outlook.
Material risks
- 1Concentration risk due to significant dependence on plasma donation programs and a limited number of large program customers.
- 2Competitive risk from larger payment networks and fintech companies that could target or underprice Paysign’s niche segments.
Verdict reasoning
two_stage score=+2/3 verdicts={'openai': 'PROCEED', 'claude': 'CAUTION', 'gemini': 'PROCEED'} brief=caller-supplied